Browse All

Current Filters

CLEAR FILTER x

TITLE

Socioeconomic and Racial Disparities in Stimulant Drug Use-associated Stroke: Trends in Mortality, Hospitalization, and Resource Use

Author:Ahmed, Muhammad   Zohaib, Muhammad   Maaz, Hafiz   Chaychi, Muhammad Tayyab Muzaffar   Sohaib, Muhammad   Shakil, Rawdah   

Session Name:P11: Cerebrovascular Disease and Interventional Neurology: Epidemiology and Community Stroke Care  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P11.020  

Author Institution:Medical College of Georgia, Augusta University, Rome, GA  Quaid-e-Azam Medical College, Pakistan  Quaid-e-Azam Medical College, Bahawalpur Pakistan, Bahawalpur, Pakistan  University of South Florida, Tampa, FL  Rollins Shool of Public Health, Emory University, Marietta, GA  Dow University of Health Sciences, Karachi, Pakistan  

Socioeconomic Disparities in Acute Stroke Care at a Safety-net Hospital: A Retrospective Cohort Study

Author:Sabra, Ahmed   Ha, Caryn   McCain, Kwame   Anne, Sraavya   Levin-Carrion, Yaxel   Sherman, Jason   Rave, Shakthi   Banat, Christina   Otite, Fadar   Feinstein, Erin   Landzberg, David   

Session Name:P11: Cerebrovascular Disease and Interventional Neurology: Epidemiology and Community Stroke Care  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P11.006  

Author Institution:Rutgers New Jersey Medical School, NJ  Rutgers New Jersey Medical School, Freehold, NJ  Rutgers New Jersey Medical School, Newark, NJ  Rutgers New Jersey Medical School, Atlanta, GA  

Solengepras, A Novel GPR6-inhibitor, Shows Potential to Improve Sleep Disturbance in Parkinson’s Disease: Results from the ASCEND Phase Two Trial

Author:Sarva, Harini   Ellenbogen, Aaron   Chou, Kelvin   Isaacson, Stuart   Pahwa, Rajesh   Merchant, Shabbir Hussain   Sheehan, Tim   Diva, Ulysses   Brice, Nicola   Charles, Michelle   Vaidya, Sagar   Xu, Xiao   Dubow, Jordan   Kieburtz, Karl   Hauser, Robert   

Session Name:P8: Movement Disorders: Parkinson's Disease Emerging Therapeutics 2  

Topic:Movement Disorders  

Program Number:P8.017  

Author Institution:Weill Cornell Medical Center, New York, NY  Quest Research Institute, Farmington Hills, MI  University of Michigan Health, Department of Neurology, Ann Arbor, MI  Parkinson's Dis & Mov Dis Ctr of Boca Raton, Boca Raton, FL  University of Kansas Medical Center, Kansas City, KS  Beth Israel Deaconess Medical Center, Boston, MA  Beacon Biosignals, MA  U Diva Statistical Consulting, CA  Cerevance, United Kingdom  Clintrex, FL  Parkinson’s Disease and Movement Disorders Center, Department of Neurology, University of South Florida, Tampa, FL  

A Solitary Enhancing Right Parietal Lesion Mimicking High-grade Glioma: An Unusual Presentation of Neurocysticercosis in the USA

Author:Jha, Shiv   Aydemir, Seyhmus   Pandit, Monika   Himes, Benjamin   Fecher, Roger   Hormigo, Adilia   

Session Name:P8: Infectious Disease: Parasitic Infections  

Topic:Infectious Disease  

Program Number:P8.006  

Author Institution:Montefiore Medical Center/ Albert Einstein College of Medicine, Bronx, NY  Montefiore Medical Center, Bronx, NY  North Central Bronx/Jacobi Medical Center, Kathmandu, Nepal  Albert Einstein College of Medicine, Bronx, NY  

A Specialized Neuroprognostication Program is Associated With Improved Guideline-adherence and Outcomes after Cardiac Arrest

Author:Fischer, David   Halablab, Saleem   Law, Connor   Schneider, Andrea   

Session Name:S21: Neurocritical Care  

Topic:Neurocritical Care  

Program Number:S21.007  

Author Institution:Dept of Neurology, Hospital of University of Pennsylvania, Philadelphia, PA  University of Pennsylvania, Philadelphia, PA